MNPR Stock Posts

MNPR Monopar Therapeutics17.83+0.90+5.3%

After Hours:15.00-2.83 (-15.9%)

Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock

Globe NewswireMon, 28-Oct 9:15 PM

MNPR Monopar Therapeutics17.83+0.90+5.3%

After Hours:15.00-2.83 (-15.9%)

Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock

Globe NewswireMon, 28-Oct 4:00 PM

MNPR Monopar Therapeutics4.61+0.02+0.5%

Premarket:5.17+0.56 (+12.0%)

Monopar Announces First Patient Dosed in Phase 1b Trial Evaluating Camsirubicin for the Treatment of Advanced Soft Tissue Sarcoma

Globe NewswireWed, 27-Oct 8:05 AM

MNPR Monopar Therapeutics5.32+0.01+0.2%

Premarket:6.18+0.86 (+16.1%)

Monopar Announces FDA Clearance to Proceed with Camsirubicin Clinical Trial Targeting Advanced Soft Tissue Sarcoma

Globe NewswireTue, 3-Aug 8:00 AM

MNPR Monopar Therapeutics Inc.8.23+0.25+3.1%

Premarket:11.79+3.56 (+43.3%)

Monopar and NorthStar Join Forces to Develop Radio-Immuno-Therapeutics (RITs) Targeting Severe COVID-19

Globe NewswireTue, 16-Jun 8:25 AM